B
Bruno Loi
Researcher at Catholic University of the Sacred Heart
Publications - 42
Citations - 685
Bruno Loi is an academic researcher from Catholic University of the Sacred Heart. The author has contributed to research in topics: Myocardial infarction & Coronary artery disease. The author has an hindex of 10, co-authored 37 publications receiving 541 citations. Previous affiliations of Bruno Loi include Vita-Salute San Raffaele University.
Papers
More filters
Journal ArticleDOI
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial
Marco Valgimigli,Enrico Frigoli,Sergio Leonardi,Pascal Vranckx,Martina Rothenbühler,Matteo Tebaldi,Ferdinando Varbella,Paolo Calabrò,Stefano Garducci,Paolo Rubartelli,Carlo Briguori,Giuseppe Andò,Maurizio Ferrario,Ugo Limbruno,Roberto Garbo,Paolo Sganzerla,Filippo Russo,Marco Stefano Nazzaro,Alessandro Lupi,Bernardo Cortese,Arturo Ausiello,Salvatore Ierna,Giovanni Esposito,Giuseppe Ferrante,Andrea Santarelli,Gennaro Sardella,Nicoletta De Cesare,Paolo Tosi,Arnoud W J van 't Hof,Elmir Omerovic,Salvatore Brugaletta,Stephan Windecker,Dik Heg,Peter Jüni,Gianluca Campo,Lucia Uguccioni,Corrado Tamburino,Patrizia Presbitero,Dennis Zavalloni-Parenti,Fabio Ferrari,Roberto Ceravolo,Fabio Tarantino,Giampaolo Pasquetto,Gavino Casu,Stefano Mameli,Maria Letizia Stochino,Pietro Mazzarotto,Alberto Cremonesi,Francesco Saia,Giovanni Saccone,Fabio Abate,Andrea Picchi,Roberto Violini,Salvatore Colangelo,Giacomo Boccuzzi,Vincenzo Guiducci,Carlo Vigna,Antonio Zingarelli,Andrea Gagnor,Tiziana Zaro,Simone Tresoldi,Pietro Vandoni,Marco Contarini,Armando Liso,Dellavalle A,Salvatore Curello,Fabio Mangiacapra,Rosario Evola,Cataldo Palmieri,Camillo Falcone,Francesco Liistro,Manuela Creaco,Antonio Colombo,Alaide Chieffo,Andrea Perkan,Stefano De Servi,Dionigi Fischetti,Stefano Rigattieri,Alessandro Sciahbasi,Edoardo Pucci,Enrico Romagnoli,Claudio Moretti,Luciano Moretti,Raffaele De Caterina,Marcello Caputo,Marco Zimmarino,Ezio Bramucci,Emilio Di Lorenzo,Maurizio Turturo,Roberto Bonmassari,Carlo Penzo,Bruno Loi,Ciro Mauro,Anna Sonia Petronio,Gabriele Gabrielli,Antonio Micari,Flavia Belloni,Francesco Amico,Marco Comeglio,Claudio Fresco,Isala Klinieken,Nicolas M. Van Mieghem,Roberto Diletti,Evelyn Regar,Manel Sabaté,José Francisco Díaz Fernández,Vicente Mainar,José M. de la Torre Hernández +107 more
TL;DR: The prespecified final 1-year outcomes of the MATRIX programme, designed to assess the comparative safety and effectiveness of radial versus femoral access and of bivalirudin versus unfractionated heparin with optional glycoprotein IIb/IIIa inhibitors in patients with the whole spectrum of acute coronary syndrome undergoing invasive management, are described.
Journal ArticleDOI
Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX.
Giuseppe Andò,Bernardo Cortese,Filippo Russo,Martina Rothenbühler,Enrico Frigoli,Giuseppe Gargiulo,Carlo Briguori,Pascal Vranckx,Sergio Leonardi,Vincenzo Guiducci,Flavia Belloni,Fabio Ferrari,José M. de la Torre Hernández,Salvatore Curello,Francesco Liistro,Andrea Perkan,Stefano De Servi,Gavino Casu,Dellavalle A,Dionigi Fischetti,Antonio Micari,Bruno Loi,Fabio Mangiacapra,Nunzio Russo,Fabio Tarantino,Francesco Saia,Dik Heg,Stephan Windecker,Peter Jüni,Marco Valgimigli,Matrix Investigators +30 more
TL;DR: In ACS patients who underwent invasive management, RA was associated with a reduced risk of AKI compared with FA, and Stratified analyses suggested greater benefit with RA than FA in patients at greater risk for AKI.
Journal ArticleDOI
Immediate and midterm outcomes following primary PCI with bioresorbable vascular scaffold implantation in patients with ST-segment myocardial infarction: insights from the multicentre "Registro ABSORB Italiano" (RAI registry).
Alfonso Ielasi,B Cortese,Attilio Varricchio,Maurizio Tespili,Marco Sesana,Francesco Pisano,Bruno Loi,Francesco Granata,Elisabetta Moscarella,Silva Orrego P,La Vecchia L,Giuseppe Steffenino,Rai registry investigators +12 more
TL;DR: BVS implantation in STEMI patients can be successfully performed with a high procedural success rate and encouraging midterm outcomes, and larger randomised trials and longer follow-up are needed to assess the potential clinical benefit of BVS versus new-generation DES in this setting.
Journal ArticleDOI
Real-world outcome of coronary bifurcation lesions in the drug-eluting stent era: results from the 4,314-patient Italian Society of Invasive Cardiology (SICI-GISE) Italian Multicenter Registry on Bifurcations (I-BIGIS).
Enrico Romagnoli,Stefano De Servi,Corrado Tamburino,Antonio Colombo,Francesco Burzotta,Patrizia Presbitero,Leonardo Bolognese,Leonardo Paloscia,Paolo Rubino,Gennaro Sardella,Carlo Briguori,Federica Ettori,Gianfranco Franco,Domenico Di Girolamo,Imad Sheiban,Luigi Piatti,Cesare Greco,Sonia Petronio,Bruno Loi,Ernesto Lioy,Alberto Benassi,Aldo Patti,Achille Gaspardone,Davide Capodanno,Giuseppe Biondi-Zoccai,Giuseppe Sangiorgi +25 more
TL;DR: This large study based on current clinical practice in an unselected patient population presenting with bifurcation disease and submitted to percutaneous coronary intervention demonstrated favorable long-term clinical results in this challenging patient setting, especially when DESs, simple stenting strategy, and DAT for at least 6 months are used.
Journal ArticleDOI
Clinical Comparison With Short-Term Follow-Up of Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Stent in Primary Percutaneous Coronary Interventions.
Bernardo Cortese,Alfonso Ielasi,Enrico Romagnoli,Attilio Varricchio,Andrea Cuculo,Bruno Loi,Francesco Pisano,Donatella Corrado,Marco Sesana,Luigi La Vecchia,Francesco Summaria,Maurizio Tespili,Pedro Silva Orrego,Gianni Tognoni,Giuseppe Steffenino +14 more
TL;DR: In this direct prospective comparison, BVS was associated with similar clinical results compared to EES in the STEMI setting and larger and adequately powered randomized trials are needed to fully assess the potential clinical benefit of BVS versus the current standard of care in patients with STEMI.